-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

Benzinga·07/13/2026 14:18:34
语音播报
RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $120 to $115.